on December 17, 2006
The founding members of the ISVR are:
Le Centre Hospitalier Universitaire Vaudois
CHUV will implement a translational research program aimed at the identification of immunological correlates of protection and the development of a platform to evaluate the immune response induced by vaccines. CHUV will also provide infrastructure for clinical trials.
The Ludwig Institute for Cancer Research
LICR engages leading scientists and clinicians in an integrated effort to understand and confront the global challenge of curing cancer.
L’Ecole Polytechnique Fédérale de Lausanne
EPFL will implement a program of basic research in virology, microbiology and the study of vectors.The close proximity of specialists in robotics and micro technology will be leveraged to encourage the development of novel automated immunological testing systems. EPFL will provide its infrastructure in proteomics, micro imaging, biomedical imaging, protein production and high throughput biomedical screening.
The Institute for Research in Biomedicine, Bellinzona
IRB will implement a program of basic rese- arch in immunology with the principal aim of characterizing memory T-cells as well as the study of the mechanisms of memory T-cell response.
